Death of the ‘Blockbuster’ and ‘Pivotal’ Clinical Trial: Rethinking the Drug Development Process

E-ISSN： 2055-2335|41|2|94-96

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.41, Iss.2, 2011-06, pp. : 94-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Economic Evaluations During Early (Phase II) Drug Development: A Role for Clinical Trial Simulations?

By Hughes D.A. Walley T.

PharmacoEconomics, Vol. 19, Iss. 11, 2001-11 ,pp. : 1069-1077

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: the Pivotal Placebo-controlled Clinical Trial

By Insull W Isaacsohn J Kwiterovich P Ma P Brazg R Dujovne C Shan M Shugrue-Crowley E Ripa S Tota R

The Journal of International Medical Research, Vol. 28, Iss. 2, 2000-03 ,pp. : 47-68

Field House Publishing

Access to resources Recommend Favorite

Clinical pharmacology in drug development — an update

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 243-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

More consequences of the death of a volunteer in a U.S. clinical trial

By Bennett FGA

Reproductive BioMedicine Online, Vol. 3, Iss. 1, 2001-07 ,pp. : 76-76

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Ground-breaking trial may change drug testing process

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite